Skip to content

Clinical trials

Approved for marketing Expanded access trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Status: Approved for marketing Clear all

244 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20045
20051
20063
20082
20091
20102
20111
20121
20132
20152

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing244

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Boehringer Ingelheim8
Gilead Sciences8
Janssen Research & Development, LLC8
AstraZeneca6
Genentech, Inc.6
Regeneron Pharmaceuticals6
Amgen4
Ionis Pharmaceuticals, Inc.4
Jazz Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung11
Recurrence11
Cholestasis9
Neoplasms8
Prostatic Neoplasms7
Breast Neoplasms6
Cystic Fibrosis6
Multiple Myeloma6
HIV Infections5
Leukemia, Myeloid, Acute4

Trials

Showing 51 to 75 of 244. Each trial links to its page on Pharma Observatory.

144 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.